Senzime AB (publ) (STO: SEZI)
Sweden
· Delayed Price · Currency is SEK
5.79
+0.09 (1.58%)
Nov 20, 2024, 4:25 PM CET
Senzime AB Revenue
Senzime AB had revenue of 17.41M SEK in the quarter ending September 30, 2024, with 90.15% growth. This brings the company's revenue in the last twelve months to 55.29M, up 87.73% year-over-year. In the year 2023, Senzime AB had annual revenue of 35.75M with 154.77% growth.
Revenue (ttm)
55.29M
Revenue Growth
+87.73%
P/S Ratio
12.60
Revenue / Employee
1.06M
Employees
52
Market Cap
656.21M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 35.75M | 21.72M | 154.77% |
Dec 31, 2022 | 14.03M | 3.05M | 27.81% |
Dec 31, 2021 | 10.98M | 1.64M | 17.60% |
Dec 31, 2020 | 9.34M | 2.63M | 39.13% |
Dec 31, 2019 | 6.71M | 3.50M | 108.81% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca PLC | 519.35B |
Swedish Orphan Biovitrum AB (publ) | 25.44B |
Sectra AB (publ) | 3.17B |
Getinge AB (publ) | 33.59B |
Camurus AB (publ) | 1.69B |
Vitrolife AB (publ) | 3.56B |
Medicover AB (publ) | 22.60B |
Elekta AB (publ) | 18.12B |
Senzime AB News
- 12 days ago - Senzime AB (SNZZF) Q3 2024 Earnings Call Highlights: Record Sales Growth and Strategic Market ... - GuruFocus
- 12 days ago - Q3 2024 Senzime AB (publ) Earnings Call Transcript - GuruFocus
- 15 days ago - Interim Report January - September 2024: Strong Sales Growth Driven by Accelerated Sensor Sales - Accesswire
- 21 days ago - New Number of Shares and Votes in Senzime AB (publ) - Accesswire
- 22 days ago - Invitation to Presentation of Senzime's Third Quarter 2024 Report - Accesswire
- 24 days ago - Senzime Successfully Unveils Next-Generation TetraGraph® Quantitative Train-of-Four Monitor at ANESTHESIOLOGY® 2024; U.S. Shipments Begin Q4 2024 - PRNewsWire
- 4 weeks ago - Bulletin From Extraordinary General Meeting in Senzime AB (publ) - Accesswire
- 4 weeks ago - Senzime Secures First European Hospital Order for its New Next-Generation TetraGraph System - Accesswire